1 Min Read
June 1 (Reuters) - CANTARGIA AB:
* CANTARGIA OBTAINS PATENT APPROVAL IN CHINA FOR THERAPY AGAINST IL1RAP IN ACUTE LYMPHOBLASTIC LEUKEMIA
* PROVIDES PROTECTION UNTIL 2030 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.